Switching From IV to Oral Meds Cuts Healthcare Costs
Switching clinically eligible patients from IV to oral medications can lower the yearly cost of healthcare, according to a recent study published online in Clinical Therapeutics.
Researchers from the Johns Hopkins University School of Medicine in Baltimore reviewed four costly medications and determined that the potential impact on hospital savings could be substantial.
Further details and the abstract are available at:
Sources: Clinical Therapeutics, HealthDay, MD News
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025